Long Focus Capital Management, LLC - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 44 filers reported holding VINCERX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Long Focus Capital Management, LLC ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$1,109,741
-22.3%
1,098,7530.0%0.04%
-38.5%
Q2 2023$1,428,379
-2.9%
1,098,753
-22.3%
0.06%
-21.7%
Q1 2023$1,471,549
+2.0%
1,414,9510.0%0.08%
-17.0%
Q4 2022$1,443,250
-1.5%
1,414,951
+33.3%
0.10%
-30.1%
Q3 2022$1,465,000
+13.2%
1,061,505
+8.3%
0.14%
+5.1%
Q2 2022$1,294,000
-24.8%
980,000
+127.8%
0.14%
-38.5%
Q1 2022$1,721,000
+20.4%
430,200
+206.8%
0.22%
+16.9%
Q4 2021$1,429,000140,2030.19%
Other shareholders
VINCERX PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,703,413$1,720,4470.48%
Tejara Capital Ltd 233,348$235,6810.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$388,8500.04%
SABBY MANAGEMENT, LLC 57,353$57,9270.04%
Long Focus Capital Management, LLC 1,098,753$1,109,7410.04%
Sio Capital Management, LLC 102,049$103,0690.03%
Rock Springs Capital Management LP 891,719$900,6360.02%
Rubric Capital Management LP 354,377$357,9210.01%
Clearline Capital LP 98,916$99,9050.01%
ExodusPoint Capital Management, LP 389,512$3930.00%
View complete list of VINCERX PHARMA INC shareholders